Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management-Reference-Cited by-同舟云学术

Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management

Published:2019-02-28 Issue:Supplement_2 Volume:57 Page:S127-S137
ISSN:1369-3786
Container-title:Medical Mycology
language:en
Short-container-title:

Author:

Girmenia Corrado¹,Busca Alessandro²,Candoni Anna³,Cesaro Simone⁴,Luppi Mario⁵,Nosari Anna Maria⁶,Pagano Livio⁷,Rossi Giuseppe⁸,Venditti Adriano⁹,Aversa Franco¹⁰

Affiliation:

1. Dipartimento di Ematologia, Oncologia, e Dermatologia, Azienda Policlinico Umberto I, Rome

2. A.O.U. Città della Salute e della Scienza, Dipartimento di Oncologia, SSD Trapianto allogenico di cellule staminali, Turin, Italy

3. Clinica Ematologica-Centro trapianti e Terapie Cellulari, Azienda Ospedaliero-Universitaria di Udine

4. Oncoematologia Pediatrica, Azienda Ospedaliera Universitaria Integrata, Verona

5. Cattedra ed UO Ematologia. Dipartimento di Scienze Mediche e Chirurgiche Materno Infantile e dell' Adulto. AOU Modena. UNIMORE. Modena

6. Divisione di Ematologia e Centro Trapianti Midollo ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

7. Istituto di Ematologia, Fondazione Policlinico A. Gemelli- IRCCS - Università Cattolica del Sacro Cuore, Rome

8. S.C. Ematologia e Dipartimento Oncologia Medica Spedali Civili, Brescia

9. Ematologia, Fondazione Policlinico Tor Vergata, Rome

10. Haematology and BMT Unit, University of Parma, Parma, Italy

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine

Link

http://academic.oup.com/mmy/article-pdf/57/Supplement_2/S127/27995422/myy091.pdf

Reference66 articles.

1. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3–2009 update;Maertens;Bone Marrow Transplant,2011

2. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011;

3. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell’Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne;Girmenia;Hematol Oncol,2013

4. Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia;Halpern;Blood,2015

5. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 Update of the Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO);Mellinghoff;Ann Hematol,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review;Clinical Infectious Diseases;2024-05-16

2. Invasive aspergillosis in liver transplant recipients in the current era;American Journal of Transplantation;2024-05

3. High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies;Microorganisms;2024-01-06

4. Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia;Scientific Reports;2023-11-01

5. Challenges in management of invasive fungal infections in stem cell transplant;Transplant Infectious Disease;2023-10-21